abs11.txt	purpose		because	of	the	escalating	cost	cancer	care	coupled	with	highinsurance	deductibles	premiums	and	uninsured	populations	patients	cancerare	affected	by	treatment-related	financial	harm	known	as	toxicity	this	study	was	to	describe	individuals	reporting	financialtoxicity	identify	rates	reasons	for	affordability-related	treatmentnoncompliance	methods	from	may	2010	november	2015	adult	(age	â‰¥	18	years)	withcancer	were	identified	a	health	registry/cancer	survivorship	cohort	defined	agreement	phrase	you	have	pay	formore	medical	than	can	afford	patient	satisfactionquestionnaire-18	logistic	regression	fisher	exact	tests	used	comparegroups	results	1	988	participants	524	(26%)	reported	patientsreporting	more	likely	age	65	years	or	younger	female	nonwhite	non-english	speaking	not	married	less	educated	receiveda	diagnosis	recently	(all	p	<	001)	toxicitywere	report	noncompliance	medication	owing	inability	toafford	prescription	drugs	(relative	risk	[rr]	3	55	95%	ci	2	53	4	98)	andreported	forgoing	mental	(rr	89	04	7	45)	doctor'svisits	98	97	51)	54	49	34)	most	endorsed	delayed	havinginsurance	coverage	being	unable	household	expenses	conclusion	25%	adults	thatwas	associated	an	increased	remains	major	issue	in	efforts	are	needed	ensurepatients	experiencing	high	levels	able	accessrecommended
